Keenova Presents a New TERLIVAZ® (terlipressin) Exploratory Analysis at American College of Gastroenterology Annual Meeting

ConferenceTERLIVAZ®Neutral

AI Analysis

Summary

Keenova Therapeutics announced a presentation of exploratory analysis data on TERLIVAZ (terlipressin) for hepatorenal syndrome-acute kidney injury at the American College of Gastroenterology Annual Meeting in October 2026.

Outcome Details

Exploratory analysis presentation on TERLIVAZ for HRS-AKI

Importance:3/10

Sentiment:

0.00

conferenceHRS-AKIterlipressingastroenterologyexploratory analysis

Related Companies

$AHR

Read the original article

Published by PR Newswire Biotech on October 12, 2026 11:30 AM

Read Original